Researchers from Taiwan concluded that although MMP-2 promoter genotypes play a minor role in the assessment of the risk of developing leukemia, the MMP-7 A-181G genotype may serve as a predictive biomarker for childhood ALL [101,102]. This evidence concerns the gene MMP2 and acute lymphoblastic leukemia.